Scientists at the Tokyo Institute of Technology (Tokyo Tech) have used a gene editing technique to establish a novel mouse model of permanent neonatal diabetes–the immune-deficient Kuma mutant mice with a specific deletion in the Insulin2 (Ins2) gene. This model is expected to be useful for studying the mechanisms governing insulin-producing cell dysfunctions in the pancreas as well as for evaluating human stem-cell derived or interspecies-derived insulin-producing cell transplantation.
- Built to last: New copolymer binder to extend the life of lithium ion batteries
- Life’s rich pattern: Researchers use sound to shape the future of printing
- New method facilitates development of antibody-based drugs
- What can stream quality tell us about quality of life?
- Sports information on social networks leaves out women, disabled and minority disciplines